No evidence of pitavastatin effect on muscle area or density among people with HIV

By afschroeder • July 25, 2025

Erlandson KM, Umbleja T, Ribaudo HJ, Lu MT, Taron J, Diggs MR, Douglas PS, Fitch KV, Fichtenbaum CJ, Zanni MV, Aberg JA, Rodriguez-Barradas MC, Breaux K, Morones RG, Sponseller CA, Currier JS, Bloomfield GS, Chu SM, Lu AB, Malvestutto CD, Grinspoon SK, Brown TT. No evidence of pitavastatin effect on muscle area or density among people with HIV. AIDS. 2025 Jul 22. doi: 10.1097/QAD.0000000000004306. Epub ahead of print. PMID: 40704993.

Tags: HIV, Infectious Diseases, muscle area, muscle density, myosteatosis, Publications, sarcopenia, statin

Implementation of a One Health Surveillance System in the Democratic Republic of the Congo

Kinzie PR, Lombe B, Merritt S, Halbrook M, Vakaniaki EH, Mukadi P, L'k'ye AM, Mona J, Kanonge D, Mfwangkang M, Witte D, Melofchik C, Muyembe-Tamfum[...]

Early antiretroviral therapy and long-term cancer risk in HIV: 9-year outcomes from the START randomized trial

Ramaswami R, Nordwall JA, Gilbert D, Kitchell E, Timiryasova A, Mitsuyasu R, Phillips AN, Lundgren J, Grabar S. Early antiretroviral therapy and long-term cancer risk[...]

Kidney abnormalities in young people living with HIV on dolutegravir-based regimens in Kampala, Uganda

Nasuuna EM, Hoffman R, Kalyesubula R, Chikwari CD, Weiss HA. Kidney abnormalities in young people living with HIV on dolutegravir-based regimens in Kampala, Uganda. AIDS[...]